CervoMed CRVO
NASDAQ CRVO
$2.62 +0.06 (+2.36%)
As of: Aug 21, 2026 · 11:29 AM EDT

CervoMed (CRVO) Net Margin (2011 - 2025)

CervoMed (CRVO) posted Net Margin of 92718.1% for Q4 2025, down 3771.16% sequentially from 2395.1% in Q3 2025, and down 9237996.0% YoY from N/an in Q4 2024.

CervoMed (CRVO) Net Margin (2011 - 2025) Analysis & Trends

CervoMed has reported Net Margin for 6 years, with the latest figure at 92718.1% in Q4 2025.

  • Quarterly Net Margin fell 9237996.0% year-over-year to 92718.1% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 1463.69% (down 124412.0% YoY) and the FY2025 annual result came in at 672.86%, down 48623.0% from the prior year.
  • Net Margin fell to 92718.1% in Q4 2025 per CRVO's latest filing, from 2395.1% in the prior quarter.
  • Over five years, Net Margin peaked at 72.61% in Q2 2023 and troughed at 92718.1% in Q4 2025.
  • A 3-year average of 8083.71% and a median of 208.52% in 2024 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2024 and 2025: Net Margin plunged 1152 bps in 2024, then sank 9237996 bps in 2025.
  • Over 3 years, Net Margin stood at 105.17% in 2023, then tumbled by 222 bps to 338.14% in 2024, then tumbled by 27320 bps to 92718.1% in 2025.
  • According to Business Quant data, Net Margin over the past three periods registered 92718.1%, 2395.1%, and 377.95% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 139.84 Bn 131.99 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 86.48 Bn 78.49 Bn 3.93 Bn 30.23%
3 Argenx Se 65.47 Bn 60.29 Bn 1.37 Bn 31.16%
4 Moderna 60.15 Bn 55.01 Bn 52.00 Mn -539.31%
5 BeOne Medicines 42.22 Bn 37.12 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 31.67 Bn 28.36 Bn 992.69 Mn 12.74%
7 BioNTech SE 28.54 Bn 10.14 Bn 668.28 Mn -16.51%
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn -3.12%
9 Royalty Pharma 27.22 Bn 26.38 Bn - 12.09%
10 CervoMed 26.53 Mn 26.53 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -92,718.10%
Sep 30, 2025 -2,395.10%
Jun 30, 2025 -377.95%
Mar 31, 2025 -278.42%
Dec 31, 2024 -338.14%
Sep 30, 2024 -244.91%
Jun 30, 2024 -92.36%
Mar 31, 2024 -110.55%
Dec 31, 2023 -105.17%
Sep 30, 2023 -172.13%
Jun 30, 2023 -72.61%
Mar 31, 2023 -99.03%
Jun 30, 2013 3,209.62%
Sep 30, 2012 -1,005.87%
Jun 30, 2012 -1,005.92%
Mar 31, 2012 -260.21%
Dec 31, 2011 -2,580.12%
Sep 30, 2011 -1,654.78%